Biomarkers and gene expression profiles for disease progression across different molecular subtypes of breast cancer
- Prosjektnummer
- 911869
- Ansvarlig person
- Elisabeth Wik
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Styrerepresetant i Kreftforeningen, avdeling Bergen, Anita Üstün, er brukerrepresentant. Hun er nylig tilkommet som dette, og vil være med på informasjonsmøter vedr prosjektet ila 2018, der en også vil drøfte evt utvidet brukermedvirkning i det videre prosjektarbeidet.
Deblender: a semi-/unsupervised multi-operational computational method for complete deconvolution of expression data from heterogeneous samples.
BMC Bioinformatics 2018 Nov 07;19(1):408. Epub 2018 nov 7
PMID: 30404611
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
PLoS One 2018;13(11):e0206665. Epub 2018 nov 1
PMID: 30383835
Transient elevation of anti-transglutaminase and anti-endomysium antibodies in Giardia infection.
Scand J Gastroenterol 2018 Jun - Jul;53(7):809-812. Epub 2018 jun 16
PMID: 29911457
Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
Hum Pathol 2017 11;69():72-80. Epub 2017 sep 18
PMID: 28923419
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.
PLoS One 2017;12(7):e0182030. Epub 2017 jul 31
PMID: 28759630
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.
Sci Rep 2017 Apr 24;7(1):1089. Epub 2017 apr 24
PMID: 28439082
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.
PLoS One 2017;12(2):e0171853. Epub 2017 feb 15
PMID: 28199370
Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Oncotarget 2017 Feb 07;8(6):9696-9707.
PMID: 28039471
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival.
J Clin Pathol 2017 Apr;70(4):313-319. Epub 2016 sep 9
PMID: 27612505
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.
PLoS One 2016;11(3):e0150979. Epub 2016 mar 8
PMID: 26954367
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers.
PLoS One 2015;10(12):e0143178. Epub 2015 des 2
PMID: 26629914
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer.
Genome Med 2015;7(1):108. Epub 2015 okt 24
PMID: 26497652
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.
Oncotarget 2015 Nov 24;6(37):39676-91.
PMID: 26485755
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.
Oncotarget 2015 Apr 30;6(12):10634-45.
PMID: 25860936
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Oncotarget 2015 Jan 20;6(2):1327-39.
PMID: 25415225
Landscape of genomic alterations in cervical carcinomas.
Nature 2014 Feb 20;506(7488):371-5. Epub 2013 des 25
PMID: 24390348
Clinical value of DNA content assessment in endometrial cancer.
Cytometry B Clin Cytom 2014 May;86(3):154-63. Epub 2014 feb 14
PMID: 24532190
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
PLoS One 2014;9(2):e90141. Epub 2014 feb 25
PMID: 24587245
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Oncotarget 2014 Feb 28;5(4):1052-61.
PMID: 24658009
An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer.
PLoS One 2014;9(6):e98787. Epub 2014 jun 6
PMID: 24905342
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Gynecol Oncol 2014 Sep;134(3):599-606. Epub 2014 jul 1
PMID: 24995579
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Mol Cancer 2014;13():223. Epub 2014 sep 27
PMID: 25261936
Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
Diagn Pathol 2014 Dec 19;9(1):230. Epub 2014 des 19
PMID: 25522915
Vascular invasion by tumor cells,and other prognostic factors in a population-based breast cancer study
- Disputert:
- februar 2018
- Hovedveileder:
- Lars A. Akslen
Biological and clinico-pathologic markers in breast cancer
- Disputert:
- juni 2017
- Hovedveileder:
- Lars A. Akslen
Markers of angiogenesis and basal-like phenotype of berast cancer
- Disputert:
- november 2017
- Hovedveileder:
- Lars A. Akslen
- Amalie Abrahamsen Svanøe Prosjektdeltaker
- Elisabeth Wik Postdoktor
- Ying Chen Ph.d.-kandidat
- Tor Audun Klingen Ph.d.-kandidat
- Kristi Krüger Ph.d.-kandidat
- Sura Mohammed Aziz Ph.d.-kandidat
- Lars A. Akslen Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest